SPORT SOUPLESSE ARTICULAIRE
Food supplement declared in France, declaration No 2016-10-604, decision dated 16 October 2016
SPORT SOUPLESSE ARTICULAIRE (ARSYLAB) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Equisetum arvense 180 mg per day, Harpagophytum procumbens 100 mg per day, Vitamin C, Sulfate de chondroïtine, Glucosamine sulfate 2 KCl. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- ARSYLAB
- Food business operator placing the product on the market
- ARSYLAB
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Sachet
- Daily dose
- 1 sachet de Poudres/jour
- Directions for use
- Diluer le mélange dans 50 cl d'eau
- Not recommended (according to the manufacturer)
- Kidney stones, Ulcer (stomach or duodenum)
- Objectives stated by the manufacturer (these are not authorised claims)
- Joints
- Flavourings
- Menthe
Declaration 276670, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Equisetum arvense L. | Parties aériennes | Extrait sec aqueux | 180 mg |
| Harpagophytum procumbens | Racine | Extrait sec aqueux | 100 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Sulfate de chondroïtine | not declared |
| Glucosamine sulfate 2 KCl | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| L-ascorbic acid | Vitamin C | no limit (insufficient data) | 180 mg |
Additives
E421, Stévia, E470b, E140
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
L'emploie est déconseillé en cas d'ulcères ou de calculs rénaux Contient des dérivés de crustacés L'emploie excessif peut causé un effet laxatif
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Harpagophytum procumbens
Read the warning, when it applies and the studies cited
DEVIL'S CLAW - HARPAGOPHYTUM
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- SPORT SOUPLESSE ARTICULAIRE ARSYLAB, declared in 2016 : different composition: 1 ingredient(s) added, 1 missing
Brand : ARSYLAB
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “SPORT SOUPLESSE ARTICULAIRE (ARSYLAB): composition and regulation”, https://compoatlas.com/en/supplements/products/276670-sport-souplesse-articulaire, updated 15 November 2026.